Ramsay Santé reported a 6.5% increase in sales for the 2024 financial year, reaching 5 billion euros, driven by growth across all regions. However, the company faced a net loss of 53.9 million euros, down from a profit of 49.4 million euros last year, due to lower subsidies, rising costs, and staff shortages, leading to a decline in Ebitda margin from 13.2% to 12.2%. CEO Pascal Roché highlighted ongoing underfunding in the healthcare sector despite efforts to secure recognition for private hospitals' contributions.
